Podcast Episodes
Back to SearchAntibody Cocktails With Immunome's Dr. Purnanand Sarma
We love to hear from our listeners. Send us a message.
Immunome CEO Purnanand Sarma, Ph.D. joins the Business of Biotech for a discussion on precisio…
3 years, 9 months ago
Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
We love to hear from our listeners. Send us a message.
Swiss-Italian biopharma company Philogen was co-founded in 1996 by three brothers, all of them…
3 years, 9 months ago
Fibroblasts In Regenerative Medicine with FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja
We love to hear from our listeners. Send us a message.
FibroBiologics Chairman, CEO, & Founder Pete O'Heeron shares the journey that led him from cli…
3 years, 10 months ago
Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management
We love to hear from our listeners. Send us a message.
To fully appreciate the work Pyxis Oncology is doing in its development of site-specific ADCs …
3 years, 10 months ago
The Biotech Beatdown With Allan Shaw
We love to hear from our listeners. Send us a message.
On this, the 100th episode of the Business of Biotech podcast, our dear friend, frequent guest…
3 years, 10 months ago
Inflammation & Antibodies with Ampio Pharmaceuticals' Mike Martino, CEO
We love to hear from our listeners. Send us a message.
Ampio Pharmaceuticals is currently weaving the gauntlet of a clinical hold triggered by COVID'…
3 years, 10 months ago
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
We love to hear from our listeners. Send us a message.
As COVID-19 cases climb yet again, the Business of Biotech catches up with Tonix Pharmaceutic…
3 years, 10 months ago
Running Interference: RNAi with Silence Therapeutics' Craig Tooman
We love to hear from our listeners. Send us a message.
Fresh on the heels of his appointment as President & CEO at Silence Therapeutics, Craig Tooman…
3 years, 11 months ago
Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
We love to hear from our listeners. Send us a message.
4D pharma's flagship early-stage clinical candidates are live biotherapeutics, a relatively ne…
3 years, 11 months ago
Gene Tx For Renal Disease With Purespring CEO Richard Francis
We love to hear from our listeners. Send us a message.
Purespring Therapeutics launched in 2020 on the back of IP developed by renowned kidney resear…
3 years, 11 months ago